BioCentury
ARTICLE | Company News

Connective Therapeutics, Genentech, Mitsubishi Chemical Corp. deal

May 20, 1996 7:00 AM UTC

CNCT acquired exclusive rights from Mitsubishi to relaxin ( ConXn) in Japan, Korea and China for undisclosed terms. Mitsubishi was the original licensee of relaxin in these Asian territories under an...